Literature DB >> 9843121

Adverse effects of cannabis.

W Hall1, N Solowij.   

Abstract

Cannabis is the most widely used illicit drug in many developed societies. Its health and psychological effects are not well understood and remain the subject of much debate, with opinions on its risks polarised along the lines of proponents' views on what its legal status should be. An unfortunate consequence of this polarisation of opinion has been the absence of any consensus on what health information the medical profession should give to patients who are users or potential users of cannabis. There is conflicting evidence about many of the effects of cannabis use, so we summarise the evidence on the most probable adverse health and psychological consequences of acute and chronic use. This uncertainty, however, should not prevent medical practitioners from advising patients about the most likely ill-effects of their cannabis use. Here we make some suggestions about the advice doctors can give to patients who use, or are contemplating the use, of this drug.

Entities:  

Mesh:

Year:  1998        PMID: 9843121     DOI: 10.1016/S0140-6736(98)05021-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  142 in total

Review 1.  Improving the quality of the cannabis debate: defining the different domains.

Authors:  J Strang; J Witton; W Hall
Journal:  BMJ       Date:  2000-01-08

2.  The cannabis policy debate: finding a way forward.

Authors:  W Hall
Journal:  CMAJ       Date:  2000-06-13       Impact factor: 8.262

3.  Cannabinoids for pain and nausea.

Authors:  E Kalso
Journal:  BMJ       Date:  2001-07-07

4.  Cannabinoid modulation of subgenual anterior cingulate cortex activation during experience of negative affect.

Authors:  Christine A Rabinak; Chandra Sekhar Sripada; Mike Angstadt; Harriet de Wit; K Luan Phan
Journal:  J Neural Transm (Vienna)       Date:  2011-12-11       Impact factor: 3.575

5.  Does marijuana have a future in pharmacopoeia?

Authors:  Giovanni Frazzetto
Journal:  EMBO Rep       Date:  2003-07       Impact factor: 8.807

6.  Typologies of cannabis users and associated characteristics relevant for public health: a latent class analysis of data from a nationally representative Canadian adult survey.

Authors:  Benedikt Fischer; Jürgen Rehm; Hyacinth Irving; Anca Ialomiteanu; Jean-Sebastien Fallu; Jayadeep Patra
Journal:  Int J Methods Psychiatr Res       Date:  2010-06       Impact factor: 4.035

7.  Grey Matter Volume Differences Associated with Extremely Low Levels of Cannabis Use in Adolescence.

Authors:  Catherine Orr; Philip Spechler; Zhipeng Cao; Matthew Albaugh; Bader Chaarani; Scott Mackey; Deepak D'Souza; Nicholas Allgaier; Tobias Banaschewski; Arun L W Bokde; Uli Bromberg; Christian Büchel; Erin Burke Quinlan; Patricia Conrod; Sylvane Desrivières; Herta Flor; Vincent Frouin; Penny Gowland; Andreas Heinz; Bernd Ittermann; Jean-Luc Martinot; Marie-Laure Paillère Martinot; Frauke Nees; Dimitri Papadopoulos Orfanos; Tomáš Paus; Luise Poustka; Sabina Millenet; Juliane H Fröhner; Rajiv Radhakrishnan; Michael N Smolka; Henrik Walter; Robert Whelan; Gunter Schumann; Alexandra Potter; Hugh Garavan
Journal:  J Neurosci       Date:  2019-01-14       Impact factor: 6.167

8.  Expectancy change and adolescents' intentions to use marijuana.

Authors:  Jessica J Skenderian; Jason T Siegel; William D Crano; Eusebio E Alvaro; Andrew Lac
Journal:  Psychol Addict Behav       Date:  2008-12

9.  Impact of Cannabis Use on the Development of Psychotic Disorders.

Authors:  Samuel T Wilkinson; Rajiv Radhakrishnan; Deepak Cyril D'Souza
Journal:  Curr Addict Rep       Date:  2014-06-01

10.  Acute and chronic effects of cannabidiol on Δ⁹-tetrahydrocannabinol (Δ⁹-THC)-induced disruption in stop signal task performance.

Authors:  David S Jacobs; Stephen J Kohut; Shan Jiang; Spyros P Nikas; Alexandros Makriyannis; Jack Bergman
Journal:  Exp Clin Psychopharmacol       Date:  2016-08-15       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.